Alvogen

Highly Engaged Employees

Alvogen, founded in 2009, is a significant player in the Pharmaceuticals and Healthcare industries, operating from its headquarters in Morristown, New Jersey. The company's core business revolves around the development, manufacturing, and global marketing of parallel imported and generic drugs. Alvogen focuses on delivering bioequivalent versions of critical medications, thereby enhancing access to affordable treatments worldwide. Its strategic approach to commercialization ensures a broad market reach for its pharmaceutical science and generic product portfolio, catering to diverse healthcare needs with efficiency and expertise.

With a substantial operational footprint, Alvogen manages its activities across 4 locations, supported by an employee base ranging from 1,000 to 5,000 individuals. This scale enables the company to effectively execute its complex drug development and distribution strategies. Alvogen is committed to innovation within the generic pharmaceutical space, continuously seeking opportunities to bring high-quality, cost-effective alternatives to market. For insights into the people driving these operations, you can Meet Alvogen's team.

The company has demonstrated robust financial performance, reporting a revenue of $945.2M. Alvogen has also secured significant funding, including a $669M debt round and a $100M stock issuance, underscoring investor confidence and its capacity for growth. Its competitive landscape includes major pharmaceutical entities such as Norgine, Salix Pharmaceuticals, and Amphastar Pharmaceuticals, among others. Alvogen's strategic positioning and financial backing support its mission to provide accessible pharmaceutical solutions globally. Investors and stakeholders can Explore financial highlights for detailed metrics.